# Unicycive Therapeutics, Inc.: Form 8-K, filed Nov 14, 2025

- Company: [Unicycive Therapeutics, Inc.](/companies/uncy.md) (CIK 1766140)
- Form: 8-K
- Filed: 2025-11-14
- Accepted by EDGAR: Nov 14, 2025, 17:10 ET
- Period: 2025-11-14
- Accession: 0001213900-25-111045
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1766140/000121390025111045/ea0265675-8k_unicycive.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1766140/000121390025111045/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1766140/000121390025111045/ea0265675-8k_unicycive.htm

Filed Nov 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-111045. Last ingested by Listed: Oct 29, 2026, 16:30 ET. No prices; not investment advice.